Carbostyril derivative
CA 1252469 A · Owner: Otsuka Pharmaceutical Co. Ltd. · Inventors: Tanaka, Tatsuyoshi; Nakagawa, Kazuyuki; Tamada, Shigeharu,
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel carbostyril derivative and its salt having, excellent platelates aggregation inhibitory effect calcium, antagonism, hypotensive effect and phosphodiesterase inhibitory effect, thus the carbostyril derivative of the present invention is useful as prophylactic or treating agent for thrombosis, circulation improving agent for coronary blood flow such as coronary vasodilator hypotensive, agent and phosphodiesterase inhibitor. Furthermore the, carbostyril derivative of the present invention is featured very weak in the hear rate increasing activity and also in the cardiac muscle contraction increasing activity the, carbostyril derivative is useful agent for curing and treating the heart …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 11, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 11, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.